Virtu Financial LLC Vir Biotechnology, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$7.63 - $12.66 $194,015 - $321,918	25,428 New	25,428 $226,000
Q2 2022 Aug 09, 2022	SELL	$19.08 - $26.7 $406,747 - $569,190	-21,318 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$21.19 - $40.01 $244,490 - $461,635	11,538 Added 117.98%	21,318 $548,000
Q4 2021 Feb 17, 2022	BUY	$30.97 - $54.03 $40,291 - $70,293	1,301 Added 15.34%	9,780 $409,000
Q3 2021 Nov 12, 2021	BUY	$34.9 - $54.54 $295,917 - $462,444	8,479 New	8,479 $369,000
Q3 2020 Dec 11, 2020	SELL	$28.28 - $53.6 $659,093 - $1.25 Million	-23,306 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$27.89 - $47.86 $650,004 - $1.12 Million	23,306 New	23,306 $955,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.